Top Research Reports for Apple, Berkshire Hathaway & Johnson & Johnson
Zacks Investment Research | Dec 03, 2020 02:58AM ET
Thursday, December 3, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (NASDAQ:AAPL), Berkshire Hathaway Inc. (NYSE:BRKa) (BRK.B) and Johnson & Johnson (JNJ). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see click here>>>
Today's Must Read/h6
Featured Reports/h6
The Zacks analyst believes that Shell's position as a major supplier of LNG should benefit its long-term cash flow growth but is worried over the decline in its hydrocarbon production.
The Zacks analyst is concerned about the downturn in Lyft's operations, thanks to coronavirus weighing significantly on ride volumes as people confine themselves to their homes.
Per the Zacks analyst, GoPro is gaining from increased camera unit sales across geographies, along with solid traction in subscription service, despite uncertainties stemming from the pandemic.
Per the Zacks analyst, Whirlpool is gaining from its cost-saving initiatives, which should enhance margins and liquidity. It generated roughly $350 million in cost savings as of the end of Q3.
Per the Zacks analyst, persistent progress and strong market of the auto and homeowners businesses have driven revenues of the company.
Per the Zacks analyst, execution of strategic initiatives and attractive business profile helps PNC improve its topline.
Per the Zacks analyst, Lockheed Martin witnesses strong demand for its aircraft programs and missile defense systems.
The Zacks analyst believes that Shell's position as a major supplier of LNG should benefit its long-term cash flow growth but is worried over the decline in its hydrocarbon production.
The Zacks analyst is concerned about the downturn in Lyft's operations, thanks to coronavirus weighing significantly on ride volumes as people confine themselves to their homes.
Per the Zacks analyst, GoPro is gaining from increased camera unit sales across geographies, along with solid traction in subscription service, despite uncertainties stemming from the pandemic.
Per the Zacks analyst, Whirlpool is gaining from its cost-saving initiatives, which should enhance margins and liquidity. It generated roughly $350 million in cost savings as of the end of Q3.
Per the Zacks analyst, persistent progress and strong market of the auto and homeowners businesses have driven revenues of the company.
Per the Zacks analyst, execution of strategic initiatives and attractive business profile helps PNC improve its topline.
Per the Zacks analyst, Lockheed Martin witnesses strong demand for its aircraft programs and missile defense systems.
New Upgrades/h6
Per the Zacks analyst, improved demand for residential products as well as increase in digital sales likely to drive Beacon Roofing performances.
The Zacks analyst is upbeat about Syneos Health's Clinical Solutions revenues showing the strongest sequential recovery amid the pandemic. Strategic partnerships also buoy optimism.
The Zacks analyst expects International Paper to gain from elevated packaging demand as well as focus on strategic acquisitions in a bid to strengthen its packaging business.
Per the Zacks analyst, improved demand for residential products as well as increase in digital sales likely to drive Beacon Roofing performances.
The Zacks analyst is upbeat about Syneos Health's Clinical Solutions revenues showing the strongest sequential recovery amid the pandemic. Strategic partnerships also buoy optimism.
The Zacks analyst expects International Paper to gain from elevated packaging demand as well as focus on strategic acquisitions in a bid to strengthen its packaging business.
New Downgrades/h6
Per the Zacks analyst, OGE Energy incurred an impairment charge of $780 million on its investment in Enable. Also, environmental regulation increases planning and operation costs of its facilities.
Per the Zacks analyst, CRISPR Therapeutics is solely dependent on Vertex for collaborations revenues, which is a concern. Stiff competition in the target market also remains a headwind.
The Zacks analyst is concerned about Inogen's decline in direct-to-consumer revenues. Softness in its Sales segment is another woe.
Per the Zacks analyst, OGE Energy incurred an impairment charge of $780 million on its investment in Enable. Also, environmental regulation increases planning and operation costs of its facilities.
Per the Zacks analyst, CRISPR Therapeutics is solely dependent on Vertex for collaborations revenues, which is a concern. Stiff competition in the target market also remains a headwind.
The Zacks analyst is concerned about Inogen's decline in direct-to-consumer revenues. Softness in its Sales segment is another woe.
Get The News You Want
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.